Idt


  • Independent Development Trust (IDT)
  • IDT Web Portal Pricing and Information
  • iDt brings you biotime
  • Integrated DNA Technologies
  • IDT Biologika
  • Intelligent Decision Technologies
  • Independent Development Trust (IDT)

    IDT Biologika GmbH is an innovative, privately-held company with more than 90 years of experience in researching, developing, manufacturing and marketing of biologics. We are a global supplier to the pharmaceutical and biotechnology industry. With decades of experience developing our own products, as well as those of pharmaceutical industry third parties, we understand the needs of our customers when it comes to responsiveness, state-of-the-art technology and integrated solutions, all set against the backdrop of a relentless commitment to quality.

    The company has experience in technically sophisticated projects, such as innovative biopharmaceuticals and lyophilised compounds. This enables us to better support customers in the US drug market and to develop closer working relationship with partners and potential customers in North America. IDT Biologika offers customers access to highly integrated development and manufacturing services, including one of the most comprehensive quality control and testing programs in the industry.

    Three business areas: pharmaceuticals, human vaccines and animal health The company focuses on three core areas: pharmaceuticals, human vaccines and animal health. For pharmaceutical markets, IDT Biologika specialises in the development and manufacture of sterile liquid drugs, providing fully-integrated services, ranging from formulation development and clinical manufacturing through to large-scale production, packaging and quality control.

    For vaccines, IDT Biologika offers development services and manufacturing facilities for clinical Phase I to III, as well as commercial supplies for leading edge viral and bacterial human vaccines, addressing health issues such as tuberculosis, AIDS, malaria and pox.

    For veterinary markets, IDT Biologika develops manufactures and markets a comprehensive range of high-quality vaccines and other products for animal health.

    Member of the Klocke Group As a member of the Klocke Group, IDT Biologika stands out in its work for the biopharmaceutical industry because of the breadth of its activities.

    The Klocke Group are experts in the areas of innovative packaging solutions and contract manufacturing of solid dosage forms and cytotoxics. Investment in enhanced production capacity In September , IDT started up its new production capacity dedicated to sterile parenteral drug products, including vaccines and biologics, having completed an expansion project announced in Capacity to manufacture vial-based products in liquid and lyophilised form will increase to 60 million units per year.

    Among the upgrades are innovative serialisation and anti-counterfeiting capabilities designed to enable the authentication of finished pharmaceuticals. Company Links.

    IDT Web Portal Pricing and Information

    Geneseeq is a research-driven company that provides cutting-edge next-generation sequencing NGS technology to accelerate precision cancer care. With headquarters in both Canada and China, Geneseeq focuses on clinical genetic testing and translational research, covering all cancers and sample types.

    The company provides a full suite of next-generation sequencing services to facilitate the research and creative endeavors of those in academia and industry. The IDT Align Program was established to broaden access to services and solutions that help move genomic research projects forward. IDT is teaming with quality partners to make NGS tools and resources more accessible, especially for researchers who need a sequencing provider tailored to their research.

    We firmly believe that advancement in precision oncology should be achieved with collaborative partners, together. This partnership will further us in the journey of novel NGS research and eventually provide patients with more treatment options and insights.

    This partnership will enable novel NGS research, which can be the building blocks to provide insight on future treatment options for patients. Its large sequencing capacity lowers cost and delivers rapid turnaround times to maximize productivity and impact of research projects. NGS solutions from IDT feature high reproducibility, customization, and scalability that break down barriers for scientists and provide them confidence in their results.

    About Geneseeq Geneseeq is a research-driven company providing cutting-edge NGS technology to accelerate precision cancer care, with headquarters in Canada and China.

    The company offers both pan-cancer panels analyzing more than genes and cancer-type specific gene panels to help match patients to optimal treatments, including targeted therapy and immunotherapy. For more information, follow Geneseeq on LinkedIn and Twitter , or visit www.

    IDT develops, manufactures, and markets nucleic acid products for the life sciences industry in the areas of academic and commercial research, agriculture, medical diagnostics, and pharmaceutical development.

    Through its GMP services, IDT manufactures products used by scientists researching many forms of cancer and most inherited and infectious diseases. IDT is widely recognized as the industry leader in custom nucleic acid manufacture, serving over , life sciences researchers.

    For more information, please visit www. Media Contact.

    iDt brings you biotime

    For pharmaceutical markets, IDT Biologika specialises in the development and manufacture of sterile liquid drugs, providing fully-integrated services, ranging from formulation development and clinical manufacturing through to large-scale production, packaging and quality control.

    Integrated DNA Technologies

    For vaccines, IDT Biologika offers development services and manufacturing facilities for clinical Phase I to III, as well as commercial supplies for leading edge viral and bacterial human vaccines, addressing health issues such as tuberculosis, AIDS, malaria and pox.

    For veterinary markets, IDT Biologika develops manufactures and markets a comprehensive range of high-quality vaccines and other products for animal health. Member of the Klocke Group As a member of the Klocke Group, IDT Biologika stands out in its work for the biopharmaceutical industry because of the breadth of its activities.

    The Klocke Group are experts in the areas of innovative packaging solutions and contract manufacturing of solid dosage forms and cytotoxics. Investment in enhanced production capacity In SeptemberIDT started up its new production capacity dedicated to sterile parenteral drug products, including vaccines and biologics, having completed an expansion project announced in Capacity to manufacture vial-based products in liquid and lyophilised form will increase to 60 million units per year.

    Among the upgrades are innovative serialisation and anti-counterfeiting capabilities designed to enable the authentication of finished pharmaceuticals.

    IDT Biologika

    The company provides a full suite of next-generation sequencing services to facilitate the research and creative endeavors of those in academia and industry. The IDT Align Program was established to broaden access to services and solutions that help move genomic research projects forward.

    IDT is teaming with quality partners to make NGS tools and resources more accessible, especially for researchers who need a sequencing provider tailored to their research. We firmly believe that advancement in precision oncology should be achieved with collaborative partners, together. This partnership will further us in the journey of novel NGS research and eventually provide patients with more treatment options and insights.

    Intelligent Decision Technologies

    This partnership will enable novel NGS research, which can be the building blocks to provide insight on future treatment options for patients. Its large sequencing capacity lowers cost and delivers rapid turnaround times to maximize productivity and impact of research projects. NGS solutions from IDT feature high reproducibility, customization, and scalability that break down barriers for scientists and provide them confidence in their results.

    About Geneseeq Geneseeq is a research-driven company providing cutting-edge NGS technology to accelerate precision cancer care, with headquarters in Canada and China.


    Posted in Idt

    thoughts on “Idt

    1. I apologise, but, in my opinion, you are not right. I am assured. I suggest it to discuss.

    Leave a Reply

    Your email address will not be published. Required fields are marked *